Skip to content
In deliveryUnited KingdomServices£9,500,000

Clinical Evaluations

Published
Published 1 February 2024
Deadline
Closed 2 July 2024

Overview

Management of Clinical evaluations, including evaluation initiation, delivery, site and data management, monitoring and analysis report writing, in order to support UKHSA's testing capabilities.<br/><br/>The maximum value of the contract will be £9.5m exc VAT over the maximum term of 5 years (3+1+1). However, there is no annual commitment and spend is subject to annual internal budgetary approval.

Key details

Country
United Kingdom
Status
In delivery
Category
Services
Estimated value
£9,500,000
Procedure
Open
Published
1 February 2024
Deadline
Closed
Classification (CPV)
Research and development services and related consultancy services

Award outcome

Awarded value
£9,500,000
Award date
2 April 2025
Contract period
8 September 2024 → 8 September 2027
Winner
  • Mac Clinical Research Finance Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    10 April 2025

    View notice ↗
  2. Contract Notice

    30 May 2024

    View notice ↗
  3. Tender Update

    2 February 2024

    View notice ↗
  4. Prior Information Notice

    1 February 2024

    View notice ↗

Contracting authority

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

    Buyer

    London, United Kingdom

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Clinical Evaluations — won by Mac Clinical Research Finance Ltd — Skim